Capital Investment Advisors LLC Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Investment Advisors LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 179.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,508 shares of the medical equipment provider's stock after purchasing an additional 1,609 shares during the period. Capital Investment Advisors LLC's holdings in Intuitive Surgical were worth $1,242,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Norges Bank purchased a new stake in Intuitive Surgical in the fourth quarter worth about $2,401,493,000. GAMMA Investing LLC lifted its holdings in shares of Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after purchasing an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC boosted its position in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider's stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Capital Research Global Investors grew its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $313,769,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG traded down $8.79 during mid-day trading on Thursday, reaching $513.62. The stock had a trading volume of 1,548,331 shares, compared to its average volume of 2,021,075. The business has a fifty day moving average of $524.49 and a 200 day moving average of $538.83. The firm has a market cap of $184.09 billion, a price-to-earnings ratio of 80.13, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The company had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same quarter in the prior year, the firm posted $1.50 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have recently commented on ISRG. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Piper Sandler decreased their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating for the company in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Finally, Truist Financial decreased their price objective on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $588.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,695,113.84. The trade was a 3.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the transaction, the senior vice president now directly owns 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,998 shares of company stock valued at $2,611,577 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.